{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:59:50Z","timestamp":1792807190246,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00228-022-03279-1","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T19:03:36Z","timestamp":1642705416000},"page":"393-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of serum levels of asprosin and other metabolic profiles in patients with idiopathic tonic\u2013clonic generalized epilepsy on treatment with valproic acid"],"prefix":"10.1007","volume":"78","author":[{"given":"Amir-mohammad","family":"Yaryari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdokht","family":"Mazdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza Rastgoo","family":"Haghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Ghiasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4119-1600","authenticated-orcid":false,"given":"Maryam","family":"Mehrpooya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"issue":"1","key":"3279_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.publhealth.22.1.355","volume":"22","author":"TL Visscher","year":"2001","unstructured":"Visscher TL, Seidell JC (2001) The public health impact of obesity. Annu Rev Public Health 22(1):355\u2013375","journal-title":"Annu Rev Public Health"},{"key":"3279_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","volume":"48","author":"E Ben-Menachem","year":"2007","unstructured":"Ben-Menachem E (2007) Weight issues for people with epilepsy\u2014a review. Epilepsia 48:42\u201345","journal-title":"Epilepsia"},{"issue":"5","key":"3279_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1528-1167.2009.02477.x","volume":"51","author":"C Hinnell","year":"2010","unstructured":"Hinnell C, Williams J, Metcalfe A, Patten SB, Parker R, Wiebe S, Jett\u00e9 N (2010) Health status and health-related behaviors in epilepsy compared to other chronic conditions\u2014a national population-based study. Epilepsia 51(5):853\u2013861","journal-title":"Epilepsia"},{"issue":"12","key":"3279_CR4","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1528-1157.1996.tb00557.x","volume":"37","author":"BJ Steinhoff","year":"1996","unstructured":"Steinhoff BJ, Neusiiss K, Thegeder H, Reimers CD (1996) Leisure time activity and physical fitness in patients with epilepsy. Epilepsia 37(12):1221\u20131227","journal-title":"Epilepsia"},{"issue":"9","key":"3279_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1212\/WNL.0b013e3181ab2b11","volume":"73","author":"Z Daniels","year":"2009","unstructured":"Daniels Z, Nick T, Liu C, Cassedy A, Glauser T (2009) Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy. Neurology 73(9):658\u2013664","journal-title":"Neurology"},{"issue":"1","key":"3279_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-013-1190-x","volume":"127","author":"EB Lee","year":"2014","unstructured":"Lee EB, Mattson MP (2014) The neuropathology of obesity: insights from human disease. Acta Neuropathol 127(1):3\u201328","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3279_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.seizure.2005.11.008","volume":"15","author":"MS Berilgen","year":"2006","unstructured":"Berilgen MS, Mungen B, Ustundag B, Demir C (2006) Serum ghrelin levels are enhanced in patients with epilepsy. Seizure 15(2):106\u2013111","journal-title":"Seizure"},{"issue":"4","key":"3279_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.seizure.2011.01.001","volume":"20","author":"Z Ataie","year":"2011","unstructured":"Ataie Z, Golzar M, Babri S, Ebrahimi H, Mohaddes G (2011) Does ghrelin level change after epileptic seizure in rats? Seizure 20(4):347\u2013349","journal-title":"Seizure"},{"issue":"3","key":"3279_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1528-1167.2006.00478.x","volume":"47","author":"J Wong","year":"2006","unstructured":"Wong J, Wirrell E (2006) Physical activity in children\/teens with epilepsy compared with that in their siblings without epilepsy. Epilepsia 47(3):631\u2013639","journal-title":"Epilepsia"},{"issue":"3","key":"3279_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.yebeh.2004.02.007","volume":"5","author":"R Kobau","year":"2004","unstructured":"Kobau R, DiIorio CA, Price PH, Thurman DJ, Martin LM, Ridings DL, Henry TR (2004) Prevalence of epilepsy and health status of adults with epilepsy in Georgia and Tennessee: Behavioral Risk Factor Surveillance System, 2002. Epilepsy Behav 5(3):358\u2013366","journal-title":"Epilepsy Behav"},{"issue":"11","key":"3279_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2165\/00023210-200317110-00002","volume":"17","author":"V Biton","year":"2003","unstructured":"Biton V (2003) Effect of antiepileptic drugs on bodyweight. CNS Drugs 17(11):781\u2013791","journal-title":"CNS Drugs"},{"issue":"5","key":"3279_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ana.410390506","volume":"39","author":"JI Isoj\u00e4rvi","year":"1996","unstructured":"Isoj\u00e4rvi JI, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllyla VV (1996) Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 39(5):579\u2013584","journal-title":"Ann Neurol"},{"issue":"7","key":"3279_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1176\/appi.ps.53.7.842","volume":"53","author":"Y Vanina","year":"2002","unstructured":"Vanina Y, Podolskaya A, Sedky K, Shahab H, Siddiqui A, Munshi F, Lippmann S (2002) Body weight changes associated with psychopharmacology. Psychiatr Serv 53(7):842\u2013847","journal-title":"Psychiatr Serv"},{"key":"3279_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.yebeh.2014.10.021","volume":"42","author":"B Chen","year":"2015","unstructured":"Chen B, Choi H, Hirsch L, Moeller J, Javed A, Kato K, Legge A, Buchsbaum R, Detyniecki K (2015) Cosmetic side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav 42:129\u2013137","journal-title":"Epilepsy Behav"},{"key":"3279_CR15","doi-asserted-by":"crossref","unstructured":"Tolou-Ghamari Z, Palizban AA (2015) Review of sodium valproate clinical and biochemical properties.\u00a0Zahedan\u00a0J\u00a0Res\u00a0Med Sci\u00a017(8)","DOI":"10.17795\/zjrms-2207"},{"issue":"8","key":"3279_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/088307389901400802","volume":"14","author":"GP Novak","year":"1999","unstructured":"Novak GP, Maytal J, Alshansky A, Eviatar L, Sy-Kho R, Siddique Q (1999) Risk of excessive weight gain in epileptic children treated with valproate. J Child Neurol 14(8):490\u2013495","journal-title":"J Child Neurol"},{"issue":"3","key":"3279_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1017\/S0317167100021879","volume":"24","author":"CL Corman","year":"1997","unstructured":"Corman CL, Leung NM, Guberman AH (1997) Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. Can J Neurol Sci 24(3):240\u2013244","journal-title":"Can J Neurol Sci"},{"key":"3279_CR18","doi-asserted-by":"crossref","unstructured":"Verrotti A, D'Egidio C, Mohn A, Coppola G, Chiarelli F (2011) Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications.\u00a0Obes Rev 12(5):e32-e43","DOI":"10.1111\/j.1467-789X.2010.00800.x"},{"key":"3279_CR19","doi-asserted-by":"crossref","unstructured":"Khan M, Joseph F (2014) Adipose tissue and adipokines: the association with and application of adipokines in obesity. Scientifica","DOI":"10.1155\/2014\/328592"},{"issue":"3","key":"3279_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B (2016) Asprosin, a fasting-induced glucogenic protein hormone. Cell 165(3):566\u2013579","journal-title":"Cell"},{"key":"3279_CR21","doi-asserted-by":"crossref","unstructured":"Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, Zheng Y, Zheng H (2018) Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion.\u00a0Mediators Inflamm","DOI":"10.1155\/2018\/9471583"},{"key":"3279_CR22","doi-asserted-by":"crossref","unstructured":"Hong T, Li J-Y, Wang Y-D, Qi X-Y, Liao Z-Z, Bhadel P, Ran L, Yang J, Yan B, Liu J-H (2020) High serum asprosin levels are associated with presence of metabolic syndrome","DOI":"10.21203\/rs.3.rs-56089\/v1"},{"key":"3279_CR23","doi-asserted-by":"crossref","unstructured":"Ugur K, Aydin S (2019) Saliva and blood asprosin hormone concentration associated with obesity.\u00a0Int\u00a0J\u00a0Endocrinol","DOI":"10.1155\/2019\/2521096"},{"key":"3279_CR24","doi-asserted-by":"crossref","unstructured":"Matthews DR, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R (1985) Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419","DOI":"10.1007\/BF00280883"},{"issue":"4","key":"3279_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4274\/Jcrpe.1127","volume":"5","author":"Y Singh","year":"2013","unstructured":"Singh Y, Garg M, Tandon N, Marwaha RK (2013) A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol 5(4):245","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1\u20132","key":"3279_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0920-1211(01)00317-5","volume":"48","author":"G Luef","year":"2002","unstructured":"Luef G, Abraham I, Trinka E, Alge A, Windisch J, Daxenbichler G, Unterberger I, Seppi K, Lechleitner M, Kr\u00e4mer G (2002) Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate. Epilepsy Res 48(1\u20132):91\u2013102","journal-title":"Epilepsy Res"},{"issue":"4","key":"3279_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/088307380201700405","volume":"17","author":"A Verrotti","year":"2002","unstructured":"Verrotti A, Basciani F, De Simone M, Trotta D, Morgese G, Chiarelli F (2002) Insulin resistance in epileptic girls who gain weight after therapy with valproic acid. J Child Neurol 17(4):265\u2013268","journal-title":"J Child Neurol"},{"key":"3279_CR28","doi-asserted-by":"crossref","unstructured":"Hamed SA, Fida NM, Hamed EA (2009) States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.\u00a0Eur\u00a0J\u00a0Paediatr\u00a0Neurol\u00a013(3):261\u2013268","DOI":"10.1016\/j.ejpn.2008.05.005"},{"issue":"5","key":"3279_CR29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","volume":"43","author":"V Pylv\u00e4nen","year":"2002","unstructured":"Pylv\u00e4nen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isoj\u00e4rvi JI (2002) Serum insulin and leptin levels in valproate-associated obesity. Epilepsia 43(5):514\u2013517","journal-title":"Epilepsia"},{"issue":"1","key":"3279_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1467-789X.2005.00159.x","volume":"6","author":"A Lihn","year":"2005","unstructured":"Lihn A, Pedersen SB, Richelsen B (2005) Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6(1):13\u201321","journal-title":"Obes Rev"},{"issue":"5","key":"3279_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0887-8994(00)00133-8","volume":"22","author":"E Demir","year":"2000","unstructured":"Demir E, Aysun S (2000) Weight gain associated with valproate in childhood. Pediatr Neurol 22(5):361\u2013364","journal-title":"Pediatr Neurol"},{"issue":"3","key":"3279_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.yebeh.2006.02.008","volume":"8","author":"V Pylv\u00e4nen","year":"2006","unstructured":"Pylv\u00e4nen V, Pakarinen A, Knip M, Isoj\u00e4rvi J (2006) Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. Epilepsy Behav 8(3):643\u2013648","journal-title":"Epilepsy Behav"},{"issue":"4","key":"3279_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1212\/01.WNL.0000048209.07526.86","volume":"60","author":"V Pylv\u00e4nen","year":"2003","unstructured":"Pylv\u00e4nen V, Knip M, Pakarinen AJ, Turkka J, Kotila M, R\u00e4tty\u00e4 J, Myllyl\u00e4 V, Isoj\u00e4rvi J (2003) Fasting serum insulin and lipid levels in men with epilepsy. Neurology 60(4):571\u2013574","journal-title":"Neurology"},{"issue":"4","key":"3279_CR34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ana.410430406","volume":"43","author":"JI Isoj\u00e4rvi","year":"1998","unstructured":"Isoj\u00e4rvi JI, R\u00e4tty\u00e4 J, Myllyl\u00e4 VV, Knip M, Koivunen R, Pakarinen AJ, Tekay A, Tapanainen JS (1998) Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 43(4):446\u2013451","journal-title":"Ann Neurol"},{"issue":"2","key":"3279_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1212\/WNL.56.2.172","volume":"56","author":"V Biton","year":"2001","unstructured":"Biton V, Mirza W, Montouris G, Vuong A, Hammer A, Barrett P (2001) Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 56(2):172\u2013177","journal-title":"Neurology"},{"key":"3279_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.seizure.2017.03.007","volume":"48","author":"HS Sidhu","year":"2017","unstructured":"Sidhu HS, Srinivas R, Sadhotra A (2017) Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: a prospective study. Seizure 48:15\u201321","journal-title":"Seizure"},{"issue":"9","key":"3279_CR37","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.0013-9580.2004.66303.x","volume":"45","author":"HA El-Khayat","year":"2004","unstructured":"El-Khayat HA, Abd El-Basset FZ, Tomoum HY, Tohamy SM, Zaky AA, Mohamed MS, Hakky SM, Barbary NSE, Nassef NM (2004) Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. Epilepsia 45(9):1106\u20131115","journal-title":"Epilepsia"},{"issue":"6","key":"3279_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ejpn.2014.07.004","volume":"18","author":"H Goldberg-Stern","year":"2014","unstructured":"Goldberg-Stern H, Yaacobi E, Phillip M, de Vries L (2014) Endocrine effects of valproic acid therapy in girls with epilepsy: a prospective study. Eur J Paediatr Neurol 18(6):759\u2013765","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"3279_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2008.05.006","volume":"39","author":"PS Espinosa","year":"2008","unstructured":"Espinosa PS, Salazar JC, Yu L, Mendiondo MS, Robertson WC, Baumann RJ (2008) Lack of valproic acid-associated weight gain in prepubertal children. Pediatr Neurol 39(3):177\u2013180","journal-title":"Pediatr Neurol"},{"key":"3279_CR40","first-page":"71","volume":"4","author":"JE Pessin","year":"2013","unstructured":"Pessin JE, Kwon H (2013) Adipokines mediate inflammation and insulin resistance. Front Endocrinol 4:71","journal-title":"Front Endocrinol"},{"issue":"1","key":"3279_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2217\/clp.09.86","volume":"5","author":"M Bl\u00fcher","year":"2010","unstructured":"Bl\u00fcher M (2010) Do adipokines link obesity to its related metabolic and cardiovascular diseases? Clin Lipidol 5(1):95\u2013107","journal-title":"Clin Lipidol"},{"issue":"11","key":"3279_CR42","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1212\/01.wnl.0000187074.27586.d1","volume":"65","author":"R Greco","year":"2005","unstructured":"Greco R, Latini G, Chiarelli F, Iannetti P, Verrotti A (2005) Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid. Neurology 65(11):1808\u20131809","journal-title":"Neurology"},{"issue":"2","key":"3279_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1528-1167.2007.01460.x","volume":"49","author":"M Rauchenzauner","year":"2008","unstructured":"Rauchenzauner M, Haberlandt E, Scholl-B\u00fcrgi S, Ernst B, Hoppichler F, Karall D, Ebenbichler CF, Rostasy K, Luef G (2008) Adiponectin and visfatin concentrations in children treated with valproic acid. Epilepsia 49(2):353\u2013357","journal-title":"Epilepsia"},{"issue":"1","key":"3279_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2007.04.001","volume":"75","author":"SA Hamed","year":"2007","unstructured":"Hamed SA (2007) Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions. Epilepsy Res 75(1):1\u20139","journal-title":"Epilepsy Res"},{"issue":"2\u20133","key":"3279_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eplepsyres.2008.03.017","volume":"80","author":"M Rauchenzauner","year":"2008","unstructured":"Rauchenzauner M, Haberlandt E, Scholl-B\u00fcrgi S, Karall D, Schoenherr E, Tatarczyk T, Engl J, Laimer M, Luef G, Ebenbichler C (2008) Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children. Epilepsy Res 80(2\u20133):142\u2013149","journal-title":"Epilepsy Res"},{"issue":"11","key":"3279_CR46","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1177\/0269881117715608","volume":"31","author":"S Akg\u00fcn","year":"2017","unstructured":"Akg\u00fcn S, K\u00f6ken T, Kahraman A (2017) Evaluation of adiponectin and leptin levels and oxidative stress in bipolar disorder patients with metabolic syndrome treated by valproic acid. J Psychopharmacol 31(11):1453\u20131459","journal-title":"J Psychopharmacol"},{"key":"3279_CR47","doi-asserted-by":"crossref","unstructured":"Mazur-Bialy AI (2021) Asprosin\u2014a fasting-induced, glucogenic, and orexigenic adipokine as a new promising player. Will it be a new factor in the treatment of obesity, diabetes, or infertility? A review of the literature. Nutrients\u00a013(2):620","DOI":"10.3390\/nu13020620"},{"key":"3279_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fendo.2020.00064","volume":"11","author":"M Yuan","year":"2020","unstructured":"Yuan M, Li W, Zhu Y, Yu B, Wu J (2020) Asprosin: a novel player in metabolic diseases. Front Endocrinol 11:64","journal-title":"Front Endocrinol"},{"issue":"5","key":"3279_CR49","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41366-018-0248-1","volume":"43","author":"C-Y Wang","year":"2019","unstructured":"Wang C-Y, Lin T-A, Liu K-H, Liao C-H, Liu Y-Y (2019) Wu VC-C, Wen M-S, Yeh T-S: Serum asprosin levels and bariatric surgery outcomes in obese adults. Int J Obes 43(5):1019\u20131025","journal-title":"Int J Obes"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-022-03279-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T04:16:34Z","timestamp":1644207394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-022-03279-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3279"],"URL":"https:\/\/doi.org\/10.1007\/s00228-022-03279-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Ethics Committee of Hamadan University of Medical Sciences, Hamadan, Iran (No: IR.UMSHA.REC.1398.399).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent"}},{"value":"Before any study procedure, all participants were completely informed regarding the research goals and data confidentiality, and all of them signed the informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Since the research does not include any information identifying individuals, there is no need for consent for publication for this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}